Файл: Северный государственный медицинский университет.docx

ВУЗ: Не указан

Категория: Не указан

Дисциплина: Не указана

Добавлен: 07.11.2023

Просмотров: 71

Скачиваний: 1

ВНИМАНИЕ! Если данный файл нарушает Ваши авторские права, то обязательно сообщите нам.
cytes compared to the negative control group (Figure 2).

Normal oral fibroblast and OKF6/TERT-2 keratino- cyte co-culture system showed a significant reduction in cell viability in 10% E-liquid concentration group following short-term exposure. In contrast, medium-




Figure 1. Tissue viability of normal oral fibroblasts and OKF6 keratinocyte monolayer cell cultures exposed to different concentrations of E-liquid as assessed by the PrestoBlue assay.




Figure 2. Tissue viability of TR146 keratinocyte mono- layer cell cultures exposed to different concentrations of E-liquid as assessed by the PrestoBlue assay.




term exposure resulted in significantly lower viability in 5% and 10% concentration groups (P<0.0001) compared to the negative control group (Figure 3). Histologically, the 3D oral mucosal models utilizing the NOFs and TR146 keratinocytes showed an in- crease in the thickness of the cancerous epithelial layer in high E-liquid concentration groups compared to the negative control after short-term and medium- term exposure (Figures 4 and 5).

Figure 6 demonstrates microscopic views of the wound healing at different stages for normal oral fi- broblasts and OKF6/TERT-2 keratinocytes. Table 1 presents the mean values and standard deviations of the total time of wound healing for the control and test groups. There was a statistically significant difference in the wound healing time of both NOF and OKF6/TERT-2 monolayer systems exposed to 1%, 5%, and 10% E-liquid solutions compared to those of the negative control group (P<0.05).

1   ...   4   5   6   7   8   9   10   11   12

Discussion


Three different cell types, including NOFs, OKF6/TERT2 keratinocytes, and cancerous TR146 keratinocytes, were used in this study. Normal oral fi- broblasts were selected as they are thought to play a major role in mucosal wound healing; they are also responsible for extracellular matrix synthesis in the connective tissue layer. OKF6/TERT-2 keratinocytes exhibit high reproducibility, avoid batch-to-batch var- iations; they were selected to represent normal oral epithelial cells. Conversely, squamous cell carci- noma-derived TR146 cells were utilized to assess the effects of E-liquid on oral cancer cells.


Figure 3. Tissue viability of normal oral fibroblast and OKF6 keratinocyte 3D co-culture systems exposed to different concentrations of E-liquid as assessed by the PrestoBlue assay.

E-liquid with no added flavors was used to elimi- nate the confounding effects of different additives that are observed with various types of flavoring agents used in E-cigarettes. Different studies have shown that certain flavors, such as menthol, cinnamon, cara- mel, butterscotch, bubble-gum, and coffee, have more cytotoxic effects on cells compared to some other fla- vors.39-41

Four different concentrations (0.1%, 1%, 5%, and 10%) of E-liquid solution were prepared to assess the effects of various concentrations of E-liquid on the cells, covering the range from light vapers to heavy e- cigarette users. The duration of exposure included three days and seven days to simulate short-term and medium-term vaping.

In this study, electronic cigarette liquid exhibited an adverse effect on the viability of normal oral



Figure 4. Histological sections of 3D tissue-engineered oral mucosa models after short-term exposure to (A) 0.1% E- liquid; (B) 1% E-liquid; (C) 5% E-liquid; (D) 10% E-liquid; (E) negative control; (F) positive control (H & E staining, original magnification ×10).





Figure 5. Histological sections of 3D tissue-engineered oral mucosa models after medium-term exposure to (A) 0.1% E-liquid; (B) 1% E-liquid; (C) 5% E-liquid; (D) 10% E-liquid; (E) negative control; (F) positive control (H & E Staining, original magnification ×10).

fibroblasts and OKF6/TERT-2 keratinocytes. These results are consistent with a previous study that tested different types of E-cigarette liquids on the human periodontal ligament fibroblasts and showed a reduc- tion in the viability of cells in the samples that were exposed to E-liquids.39

Conversely, a dose-dependent stimulatory effect of E-liquid on the growth of cancerous TR146 cells was observed in our study, exhibiting increased viability and proliferation of TR146 cells with increasing con- centrations of E-liquid. Similarly, histological evalu- ation of the 3D oral mucosa models showed an in- crease in the thickness of the cancerous epithelial layer exposed to high concentrations of E-liquid. This is the first study reporting the use of a full-thickness

3D tissue-engineered oral mucosal model for the bio- logical evaluation of electronic cigarettes on cancer- ous oral tissues. These findings have not been re- ported previously and might indicate tumor-promot- ing effects of the ingredients of the E-liquid tested in this study.

Previous studies have raised some concerns regard- ing the potential effects of nicotine on promoting tu- mors in the lungs through various possible mecha- nisms, such as cell migration, proliferation and angi- ogenesis.20-21

The influence of nicotine on dysplastic oral keratinocyte cell line and precancerous lesions of the mouse tongue has been investigated previously, showing an inhibitory effect on apoptosis and a



Figure 6. Microscopic views of the wound healing assay showing (A) the center of the wound on day 1 of fibroblast culture; (B) central wound on day 3 of fibroblast culture; (C) completely healed fibroblast cultures; (D) the center of the wound on day 1 of keratinocyte culture; (E) central wound on day 3 of keratinocyte culture; and (F) completely healed keratinocyte cultures.




Table 1. Mean values and standard deviations of the to- tal time of wound healing for the control and test groups


Cells

Groups

Mean (days)

SD

NOF

0.1% E-liquid

6.17

0.75

1% E-liquid

7.33

0.51

5% E-liquid

9.167

0.75

10% E-liquid

12.33

1.03

Control (DMEM)

5.17

0.41

OKF6/ TERT2

0.1% E-liquid

6.00

0.63

1% E-liquid

6.67

0.52

5% E-liquid

7.67

0.52

10% E-liquid

10.50

0.84

Control (DMEM)

5.05

0.63

stimulatory effect on the growth of oral precancerous lesions.44 Similarly, Chernyavsky et al42 assessed the tumor-promoting effects of nicotine on oral and lung cancer cells. Nicotine exhibited resistance to apopto- sis, increasing the counts of both lung and oral cancer cells.

Some other studies have used monolayer cell cul- ture systems to assess the cytotoxicity of electronic cigarettes.39-43 Different types of cell lines have been exposed to either electronic cigarette aerosols or E- liquid solutions. These studies have also confirmed the adverse effects of E-cigarettes, with some cell lines being more sensitive than the others.

Recently, studies have been conducted to assess the effects of electronic cigarettes on oral mucosal cells. In a study by Yu et al,43 electronic cigarette exposure reduced cell viability along with high levels of apop- tosis and necrosis, with alterations in augmented DNA strands, in normal epithelial and squamous cell carcinoma (head and neck) cell lines. However, Gut- tenplan et al44 observed a stimulatory effect of E-cig- arette exposure on the proliferation of human oral leu- koplakia cells. Conversely, Willershausen et al37 re- ported a reduction in cell proliferation of periodontal ligament fibroblasts after exposure to various E-liq- uids.

Sundar et al45 utilized human periodontal ligament fibroblasts and a 3D gingival epithelium-only tissue model to assess the effects of electronic cigarettes, re- porting an increase in pro-inflammatory cytokines and an elevated oxidative/carbonyl stress resulting in the production of high levels of cyclooxygenase-2 and prostaglandin E2. Although the 3D split-thickness tis- sue model used in this study was more clinically rele- vant than monolayer cell culture systems, it lacked the connective tissue component.

A study by Sancilio et al46 raised concerns regarding E-cigarette’s role in the pathogenesis of oral diseases. Human gingival fibroblasts exposed to E-Liquids showed decreased production of collagen I and in- creased levels of lactate dehydrogenase.

There is a lack of research on the effects of E-ciga- rettes on human oral mucosa wound healing. It has been indicated that exposure to E-cigarettes reduces the viability of cells and compromises cell migra- tion.46 Therefore, this study aimed to investigate the effects of E-cigarette liquids with different concentra- tions on oral mucosa wound healing. Two wound healing models were used in this study based on nor- mal oral fibroblasts to represent connective tissue wound healing and OKF6/TERT2 keratinocytes to simulate epithelial wound healing. The results of this in vitro assay were consistent with the results of the cytotoxicity tests and indicated that the E-liquid tested in this study might have potential dose-dependent ad- verse effects on oral mucosa wound healing, prolong- ing the healing times both in the epithelial and the connective tissue layers. In a recent study,47 human gingival fibroblasts were exposed to three different groups (cigarette smoke condensate, nicotine-free or nicotine-rich electronic cigarette vapor condensates), and the results showed that both cigarette smoke and electronic cigarette vapors affected the proliferation and migration of fibroblasts. Additionally, the cell scratch test revealed delayed wound healing, con- sistent with the findings of this study.

There were certain limitations in our study; firstly, this was an in-vitro study, and the results may not be extrapolated to an in-vivo situation. Secondly, only E- liquids were tested in this study rather than the E-cig- arette aerosols. Ideally, the cytotoxic effects of E-cig- arettes should be assessed in both liquid and vapor form, as the E-cigarette vapors come into direct con- tact with oral mucosa.

Hence, further research is required to overcome these limitations by assessing E-cigarettes of different flavors and various concentrations of nicotine. The liquid, as well as the vapor form of E-cigarettes, can be tested and compared with the conventional ciga- rette smoke. Furthermore, evaluating the long-term effects of E-cigarettes would further add to our under- standing of the biological effects of E-cigarettes on human oral tissues.

1   ...   4   5   6   7   8   9   10   11   12

Conclusion


This in vitro study revealed that short-term and me- dium-term exposure to the electronic cigarette liquid had dose-dependent cytotoxic effects on normal hu- man oral fibroblasts and OKF6/TERT-2 oral keratino- cytes. However, E-liquid exposure had a cumulative stimulatory effect on the growth of cancerous TR146 keratinocytes using both monolayer and 3D cell cul- ture systems.

The full-thickness 3D tissue-engineered human oral




mucosal model has the potential to be used as a clini- cally relevant biological test system for the evaluation of electronic cigarettes.

In addition, E-liquid exposure prolonged the wound healing of both normal oral fibroblasts and OKF6/TERT-2 epithelial cells.

Competing Interests

The authors declare no conflict(s) of interest related to the publication of this work.

Authors’ Contributions

Conceptualization, Z.S., A.A., T.A., K.F., L.T. and K.M.; Data curation, Z.S. and A.A.; Investigation, Z.S., A.A., T.A., K.F., L.T. and K.M.; Methodology, Z.S., A.A., T.A.

and K.F.; Supervision, L.T. and K.M.; Validation, Z.S., and A.A.; Writing—original draft, Z.S. and A.A.; Writing—re- view and editing, T.A., K.F., L.T. and K.M.

Acknowledgments

The authors would like to acknowledge Cancer Research UK for kindly providing the TR146 cell line and Brigham and Women's Hospital, Harvard Institute of Medicine, for providing the immortalized OKF6/TERT-2 human oral keratinocyte cell line.

Funding

This research received no external funding.

Ethics Approval

This study has been approved by National Research Ethics Service, NRES Committee London—Hampstead. Re- search Ethics Committee (REC) Reference number: 15/LO/0116; date of approval: 21/01/2015.

References


  1. Chapman SL, Wu LT. E-cigarette prevalence and correlates of use among adolescents versus adults: a review and com- parison. Journal of psychiatric research. 2014 Jul 1; 54:43-54.

  2. Dockrell M, Morrison R, Bauld L, McNeill A. E-cigarettes: prevalence and attitudes in Great Britain. Nicotine & To- bacco Research. 2013 Oct 1;15(10):1737-44.

  3. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user prefer- ences and nicotine delivery: randomised cross-over trial. To- bacco control. 2010 Apr 1;19(2):98-103.

  4. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N. Electronic cigarettes for smoking ces- sation: a randomised controlled trial. The Lancet. 2013 Nov 16;382(9905):1629-37.

  5. Caponnetto P, Auditore R, Russo C, Cappello G, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. International journal of environmental research and public health. 2013 Feb;10(2):446-61.

  6. Hadwiger ME, Trehy ML, Ye W, Moore T, Allgire J, West- enberger B. Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass

spectrometric detection. Journal of chromatography A. 2010 Nov 26;1217(48):7547-55.

  1. Pellegrino RM, Tinghino B, Mangiaracina G, Marani A, Vi- tali M, Protano C, Osborn JF, Cattaruzza MS. Electronic cig- arettes: an evaluation of exposure to chemicals and fine par- ticulate matter (PM). Ann Ig. 2012 Jul;24(4):279-88.

  2. Kim, H.J. and Shin, H.S., 2013. Determination of tobacco- specific nitrosamines in replacement liquids of electronic cigarettes by liquid chromatography–tandem mass spectrom- etry. JournalofChromatographyA, 1291, pp.48-55.

  3. Etter JF, Zäther E, Svensson S. Analysis of refill liquids for electronic cigarettes. Addiction. 2013 Sep;108(9):1671-9.

  4. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska-Czapla M, Rosik- Dulewska C, Havel C, Jacob P. Levels of selected carcino- gens and toxicants in vapour from electronic cigarettes. To- bacco control. 2014 Mar 1;23(2):133-9.

  5. Jensen RP, Luo W, Pankow JF, Strongin RM, Peyton DH. Hidden formaldehyde in e-cigarette aerosols. New England Journal of Medicine. 2015 Jan 22;372(4):392-4.

  6. Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PloS one. 2013 Mar 20;8(3):e57987.

  7. Robertson OH, Loosli CG, Puck TT, Wise H, Lemon HM, Lester W. Tests for the chronic toxicity of propylexe glycol and triethylene glycol on monkeys and rats by vapor inhala- tion and oral administration. Journal of Pharmacology and Experimental Therapeutics. 1947 Sep 1;91(1):52-76.

  8. Werley MS, McDonald P, Lilly P, Kirkpatrick D, Wallery J, Byron P, Venitz J. Non-clinical safety and pharmacokinetic evaluations of propylene glycol aerosol in Sprague-Dawley rats and Beagle dogs. Toxicology. 2011 Sep 5;287(1-3):76- 90.

  9. Wieslander G, Norbäck D, Lindgren T. Experimental expo- sure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occupational and Envi- ronmental Medicine. 2001 Oct 1;58(10):649-55.

  10. Renne RA, Wehner AP, Greenspan BJ, Deford HS, Ragan HA, Westerberg RB, Buschbom RL, Burger GT, Hayes AW, Suber RL, Mosberg AT. 2-Week and 13-week inhalation studies of aerosolized glycerol in rats. Inhalation toxicology. 1992 Jan 1;4(2):95-111.

  11. Sussan TE, Gajghate S, Thimmulappa RK, Ma J, Kim JH, Sudini K, Consolini N, Cormier SA, Lomnicki S, Hasan F, Pekosz A. Exposure to electronic cigarettes impairs pulmo- nary anti-bacterial and anti-viral defenses in a mouse model. PloS one. 2015 Feb 4;10(2):e0116861.

  12. Misra M, Leverette R, Cooper B, Bennett M, Brown S. Com- parative in vitro toxicity profile of electronic and tobacco cig- arettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols. Interna- tional journal of environmental research and public health. 2014 Nov;11(11):11325-47.

  13. Jacobi J, Jang JJ, Sundram U, Dayoub H, Fajardo LF, Cooke JP. Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. The American journal of pathology. 2002 Jul 1;161(1):97-104.

  14. Schaal C, Chellappan SP. Nicotine-mediated cell prolifera- tion and tumor progression in smoking-related cancers. Mo- lecular Cancer Research. 2014 Jan 1;12(1):14-23. Murray RP, Connett JE, Zapawa LM. Does nicotine replace- ment therapy cause cancer? Evidence from the Lung Health Study. Nicotine & Tobacco Research. 2009 Jul 1;11(9):1076-





82.

  1. Broughton G, Janis J, Attinger CE. The basic science of wound healing. Plast Reconstr Surg2006. p. 12S-34S.

  2. Campos AC, Groth AK, Branco AB. Assessment and nutri- tional aspects of wound healing. Curr Opin Clin Nutr Metab Care. 2008;11(3):281-8.

  3. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958- 69.

  4. Gosain A, DiPietro LA. Aging and Wound Healing. World J Surg. 2004;28(3):321-6.

  5. Guo S, Dipietro L. Critical Review in Oral Biology & Medi- cine: Factors Affecting Wound Healing. Houston: American Association for Dental Research/American Academy of Im- plant Dentistry; 2010. p. 219-29.

  6. Farsalinos K, Tsiapras D, Kyrzopoulos S, Voudris V. Acute and Chronic Effects of Smoking on Myocardial Function in Healthy Heavy Smokers: A Study of D oppler Flow, D oppler Tissue Velocity, and Two‐Dimensional Speckle Tracking Echocardiography. Echocardiography. 2013 Mar;30(3):285- 92.

  7. Van Staden SR, Groenewald M, Engelbrecht R, Becker PJ, Hazelhurst LT. Carboxyhaemoglobin levels, health and life- style perceptions in smokers converting from tobacco ciga- rettes to electronic cigarettes. South African medical journal. 2013;103(11):864-8.

Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopou- lou V, Connolly GN, Behrakis PK. Short-term pulmonary ef- fects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest. 2012 Jun 1;141(6):1400-6.

  1. Schober W, Szendrei K, Matzen W, Osiander-Fuchs H, Heit- mann D, Schettgen T, Jörres RA, Fromme H. Use of elec- tronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. Interna- tional journal of hygiene and environmental health. 2014 Jul 1;217(6):628-37.

  2. Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kosti- kas K, Tzatzarakis MN, Wallace Hayes A, Tsatsakis AM, Koutedakis Y. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inha- lation toxicology. 2013 Feb 1;25(2):91-101.

  3. Farsalinos KE, Polosa R. Safety evaluation and risk assess- ment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Therapeutic advances in drug safety. 2014 Apr;5(2):67-86.

  4. Hua M, Alfi M, Talbot P. Health-related effects reported by electronic cigarette users in online forums. Journal of medi- cal Internet research. 2013 Apr;15(4).

  5. Polosa R, Morjaria JB, Caponnetto P, Campagna D, Russo C, Alamo A, Amaradio M, Fisichella A. Effectiveness and tol- erability of electronic cigarette in real-life: a 24-month pro- spective observational study. Internal and emergency medi- cine. 2014 Aug 1;9(5):537-46. Dawkins L, Turner J, Roberts A, Soar K. ‘Vaping’profiles and preferences: an online survey of electronic cigarette us- ers. Addiction. 2013 Jun;108(6):1115-25.

  6. Etter JF, Bullen C. Electronic cigarette: users profile, utiliza- tion, satisfaction and perceived efficacy. Addiction. 2011 Nov;106(11):2017-28.

  7. Manzoli L, La Vecchia C, Flacco ME, Capasso L, Simonetti V, Boccia S, Di Baldassarre A, Villari P, Mezzetti A, Cicolini

G. Multicentric cohort study on the long-term efficacy and safety of electronic cigarettes: study design and methodology.

BMC public health. 2013 Dec;13(1):883.

  1. Reuther WJ, Brennan PA. Is nicotine still the bad guy? Sum- mary of the effects of smoking on patients with head and
    1   ...   4   5   6   7   8   9   10   11   12